Holly Holmes, Ph.D., is director of product development at Elysium Health. With over six years of academic research and industry experience, Holmes evaluates emerging areas of technology and presents product development updates to key stakeholders, including Elysium’s Scientific Advisory Board.
Holmes graduated with a B.Sc. (Hons) in chemistry from the University of Liverpool, holds an M.Res. in bioimaging sciences from Imperial College London, and a Ph.D. in medical and biomedical imaging from University College London. Before joining Elysium Health, Holmes was a postdoctoral research fellow at NYU Langone Medical Center.